Alexandre Marcolino | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Dr. Alexandre Marcolino | Medicine and Health Sciences | Best Researcher Award

The Patient Specific Functional Scale at Federal University of Santa Catarina, Brazil

Dr. Alexandre Marcio Marcolino is a distinguished Brazilian physiotherapist and researcher, currently serving as an Adjunct Professor at the Universidade Federal de Santa Catarina (UFSC). With a Ph.D. in Physiotherapy and Functional Performance and a Master’s in Health Sciences applied to the Locomotor System from the prestigious Faculdade de Medicina de Ribeirão Preto – USP, Dr. Marcolino has built a career centered on advanced musculoskeletal rehabilitation, low-intensity laser therapy, and electromyography. His academic journey includes specializations in hand therapy and orthopedic physiotherapy, complemented by a postdoctoral fellowship at UFSCAR. Actively involved in teaching, research, academic advisory, and program coordination, he also demonstrates a strong commitment to continuing education through numerous certifications and professional courses. His research, technical production, and contributions to clinical physiotherapy and academic leadership make him a notable figure in rehabilitation sciences in Brazil.

Professional Profile 

🎓 Education of Alexandre Marcio Marcolino 

Dr. Alexandre Marcio Marcolino holds a robust academic background in the field of physiotherapy and rehabilitation. He earned his undergraduate degree in Physiotherapy from Faculdade de Filosofia, Ciências e Letras de Catanduva in 2004, where he conducted early research on laser therapy in ischemic skin flaps. He went on to complete a Master’s degree in Health Sciences Applied to the Locomotor System (2009) and a Doctorate in Physiotherapy and Functional Performance (2013) at the Faculdade de Medicina de Ribeirão Preto – USP, focusing on laser therapy in nerve regeneration and electromyographic analysis in wrist orthoses, respectively. Additionally, he has completed two specializations—one in Hand Therapy at the Instituto de Ortopedia e Traumatologia (USP), and another in Orthopedic Physiotherapy at the Hospital das Clínicas de Ribeirão Preto. Further advancing his academic career, Dr. Marcolino completed a postdoctoral fellowship at the Universidade Federal de São Carlos (2020–2021). His commitment to lifelong learning is further demonstrated by over 30 professional development courses in areas such as electromyography, manual therapy, pedagogy, systematic reviews, and digital tools for education.

💼 Professional Experience of Alexandre Marcio Marcolino 

Dr. Alexandre Marcio Marcolino has amassed extensive professional experience in academia, clinical practice, and research within the field of physiotherapy. Since 2015, he has served as an Adjunct Professor at the Universidade Federal de Santa Catarina (UFSC), where he is actively involved in teaching undergraduate and postgraduate courses, supervising research in the Postgraduate Program in Rehabilitation Sciences, and contributing to academic administration, including roles such as program coordinator and departmental delegate. His clinical and academic expertise spans orthopedics and traumatology, with a focus on electromyography, rehabilitation techniques, and musculoskeletal disorders. Prior to his tenure at UFSC, he worked as a professor at the Universidade Estadual de Goiás (UEG) and gained hands-on clinical experience as a physiotherapist at the Casa de Repouso Brandão and through his residency at the Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto – USP. Dr. Marcolino’s diverse professional background integrates clinical proficiency, academic leadership, and a strong research orientation, making him a key contributor to the advancement of physiotherapy in Brazil.

🔬 Research Interests of Alexandre Marcio Marcolino 

Dr. Alexandre Marcio Marcolino’s research interests are centered on advancing clinical practices in physiotherapy through evidence-based approaches in musculoskeletal rehabilitation and neurofunctional recovery. He has a strong focus on electromyography, biomechanical analysis, and the application of low-intensity laser therapy for tissue repair and nerve regeneration—particularly in experimental models of peripheral nerve injury. His academic investigations also explore the therapeutic effects of orthotic devices, muscle activation patterns, and functional performance, especially in conditions like lateral epicondylitis. Additionally, Dr. Marcolino is deeply engaged in interdisciplinary studies that intersect biomechanics, manual therapy, and innovative physiotherapeutic techniques aimed at improving clinical outcomes. His commitment to scientific rigor and translational research reflects a broader vision to enhance rehabilitation protocols and contribute to the development of high-impact, patient-centered care models.

🏅 Awards and Honors of Alexandre Marcio Marcolino 

Dr. Alexandre Marcio Marcolino has been recognized for his academic excellence and research contributions through prestigious awards and honors throughout his career. Notably, he received a postdoctoral research fellowship from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)—a significant acknowledgment of his scholarly merit and potential for advancing rehabilitation sciences in Brazil. Earlier in his career, he was also granted a scholarship from FUNDAP (Fundação do Desenvolvimento Administrativo) during his specialization in orthopedic physiotherapy at the renowned Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto – USP. These honors reflect his dedication to scientific advancement, clinical excellence, and ongoing contributions to the field of physiotherapy.

✅ Conclusion

Dr. Alexandre Marcio Marcolino is a highly suitable candidate for the Best Researcher Award in the health and rehabilitation sciences. His profound academic qualifications, consistent research contributions, and dedication to education, combined with a diversified skill set in therapy techniques and bioinstrumentation, place him among top-tier professionals in Brazilian physiotherapy research.

📝 Selected Publications by Dr. Shahrokh Javaheri

  1. Title: Photobiomodulation (100 mW) caution applied to tattooed skin: a cross-sectional study
    Authors: [Author names not fully visible]
    Journal: Archives of Dermatological Research
    Year: 2025
    Citations: 0

  2. Title: Effects of Transcutaneous Electrical Nerve Stimulation (TENS) During Functional Activities or Exercise: A Systematic Review
    Authors: [Author names not fully visible]
    Year: [Not explicitly mentioned; assumed recent]
    Citations: 0

  3. Title: Influence of photobiomodulation and radiofrequency on the healing of pressure lesions in mice
    Authors: [Author names not fully visible]
    Journal: Lasers in Medical Science
    Year: 2024
    Citations: 0

  4. Title: The Patient Specific Functional Scale – Brazil as an instrument for the functional assessment of patients with chronic non-specific low back pain: Construct validity (hypothesis testing and structural validity) and test-retest reliability
    Authors: [Author names not fully visible]
    Journal: Musculoskeletal Science and Practice
    Year: 2024
    Citations: 0

  5. Title: Does the skin phototype influence the sensory perception of individuals during photobiomodulation irradiation?
    Authors: [Author names not fully visible]
    Journal: Archives of Dermatological Research
    Year: 2024
    Citations: 1

 

 

 

 

Shahrokh Javaheri | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Shahrokh Javaheri | Medicine and Health Sciences | Best Researcher Award

Sleep Physicia at Bethesda North Hospital, United States

Dr. Shahrokh Javaheri is a highly respected Professor Emeritus at the University of Cincinnati College of Medicine and a leading figure in pulmonary and sleep medicine. With medical training from Pahlavi University and advanced research fellowships at prestigious institutions such as Harvard Medical School and the University of Pennsylvania, he has built an illustrious career spanning over 40 years. He has held numerous influential roles, including Director of Pulmonary Function and Sleep Disorders Laboratories at the Veterans Affairs Medical Center in Cincinnati, and served as a consultant and clinical leader at multiple institutions. Board-certified in Internal Medicine, Pulmonary Medicine, Critical Care, and Sleep Medicine, Dr. Javaheri has contributed significantly to clinical research, academic mentorship, and patient care. His active affiliations with leading societies like the American Thoracic Society and the European Respiratory Society highlight his ongoing influence in the global medical community. Through his enduring dedication to science and medicine, Dr. Javaheri continues to shape the field with his expertise and clinical insight.

Professional Profile 

🎓 Education Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri received his foundational medical education at Pahlavi University Medical School (now Shiraz University of Medical Sciences) in Shiraz, Iran, where he earned his M.D. in 1970. He began his postgraduate training with clinical exposure in the Pulmonary Unit at Massachusetts General Hospital in Boston during 1969–1970, laying the groundwork for his future specialization. Following his internship and national service as a medical officer in Iran, he pursued an internal medicine residency at Pahlavi Medical School. To further specialize, he completed a renal fellowship at the University of Pennsylvania and then underwent rigorous clinical and research fellowships in Pulmonary Medicine at Massachusetts General Hospital, affiliated with Harvard Medical School, from 1975 to 1978. His education and training reflect a blend of international excellence and intensive specialization, forming a strong foundation for his subsequent contributions to pulmonary and sleep medicine.

💼 Professional Experience Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri has had a distinguished and extensive professional career spanning over four decades in academic medicine, clinical practice, and research. He began his academic journey as an Assistant Professor of Medicine at Boston University School of Medicine (1978–1980), concurrently serving as Director of the Pulmonary Function Laboratories at Boston City Hospital. He later contributed internationally as an Associate Researcher at Ghent University in Belgium before relocating to Cincinnati, where he became a central figure in pulmonary and sleep medicine. From 1983 to 2003, he held key positions at the Veterans Affairs Medical Center, including Director of the Pulmonary Function and Sleep Disorders Laboratories and Assistant Chief of the Pulmonary Section. Simultaneously, he served at the University of Cincinnati College of Medicine, rising from Associate Professor to Professor of Medicine, specializing in Pulmonary Disease and Critical Care. Following his transition to Professor Emeritus in 2003, he remained actively engaged in clinical practice as a Sleep Physician at Bethesda North Hospital and a consultant with the Will Rogers Institute. His career reflects a rare combination of clinical leadership, academic excellence, and dedication to advancing patient care in pulmonary and sleep medicine.

🔬 Research Interests Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri’s research interests are centered on sleep-disordered breathing, heart failure-related sleep apnea, pulmonary physiology, and the intersection of sleep medicine with cardiovascular disease. A pioneer in the clinical study of central and obstructive sleep apnea, he has contributed significantly to understanding how sleep-related breathing disorders impact cardiac function and overall health outcomes. His work has explored the mechanisms and treatment responses in patients with Cheyne-Stokes respiration, chronic heart failure, and sleep-related hypoventilation, making him a leading authority in this nuanced and evolving field. Dr. Javaheri’s research also emphasizes the use of non-invasive ventilation therapies, such as CPAP and adaptive servo-ventilation, and their clinical outcomes. His multidisciplinary approach bridges pulmonology, sleep medicine, and cardiology, reflecting a deep commitment to translating physiological insights into effective clinical interventions for complex, high-risk patient populations.

🏅 Awards and Honors Summary: Dr. Shahrokh Javaheri

Dr. Shahrokh Javaheri has been recognized with numerous honors and distinctions throughout his extensive career, reflecting his outstanding contributions to pulmonary and sleep medicine. He holds the prestigious title of Professor Emeritus at the University of Cincinnati College of Medicine, a recognition reserved for faculty with exceptional academic and clinical service. His board certifications in Internal Medicine, Pulmonary Medicine, Critical Care, and Sleep Medicine underscore his elite professional standing. In addition, he is a Fellow of the American Academy of Sleep Medicine, a mark of distinction for leaders in the field. Dr. Javaheri’s enduring affiliations with premier medical societies, including the American Thoracic Society, American College of Chest Physicians, and European Respiratory Society, further highlight his respected status in the global medical community. His roles as a clinical consultant, academic mentor, and sleep medicine expert have earned him lasting recognition and respect across institutions and disciplines.

✅ Conclusion:

Dr. Shahrokh Javaheri is highly suitable for the Best Researcher Award, particularly in the domains of Sleep Medicine, Pulmonary Disease, and Internal Medicine. His prolific and sustained career, board-certified expertise, academic appointments, and clinical leadership establish him as a well-rounded and impactful physician-researcher. With minor enhancement in showcasing recent research metrics or translational innovations, his profile would stand as exemplary on both national and international fronts.

📝 Selected Publications by Dr. Shahrokh Javaheri

  1. Title: Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review
    Authors: Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T, Javaheri S
    Year: 2020
    Citations: 19

  2. Title: Treatment of OSA and its Impact on Cardiovascular Disease, Part 2: JACC State-of-the-Art Review
    Authors: Somers VK, Javaheri S, et al.
    Year: 2020
    Citations: 10

  3. Title: Medication-induced central sleep apnea: a unifying concept
    Authors: Javaheri S, Dempsey JA
    Year: 2022
    Citations: 7

  4. Title: Distinguishing central from obstructive hypopneas on a clinical polysomnogram
    Authors: Javaheri S, Malhotra A
    Year: 2021
    Citations: 19

  5. Title: Cardiovascular Risks in People With Narcolepsy: Expert Panel Consensus Recommendations
    Authors: Javaheri S, Black J, Foldvary-Schaefer N, Malhotra RK, Zee PC, et al.
    Journal: Journal of the American Heart Association
    Year: 2024
    Citations: 1

  6. Title: A call for precision medicine: Facing the challenge of sleep-disordered breathing in heart failure
    Authors: Javaheri S, et al.
    Type: Editorial
    Year: 2023
    Citations: 1

  7. Title: Sleep, Hypoxia, and Survival in Group 1 Pulmonary Arterial Hypertension: What to Do?
    Authors: Javaheri S
    Type: Editorial
    Year: 2023
    Citations: 0

  8. Title: Guest editorial: Phrenic nerve stimulation for treatment of central sleep apnea
    Author: Javaheri S
    Year: 2022
    Citations: 0

 

Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Prof. Yashwant Pathak | Medicine and Health Sciences | Best Researcher Award

Professor at Univ of South Florida Taneja College of Pharmacy, United States

Professor Yashwant V. Pathak is a globally renowned pharmaceutical scientist, educator, and research leader with a distinguished academic and international career spanning over four decades. Currently serving as Associate Dean and Full Professor at the University of South Florida’s Taneja College of Pharmacy, he has made groundbreaking contributions in nanotechnology, drug delivery systems, nutraceuticals, and healthcare education. A recipient of prestigious honors such as the Fellowship of the American Association for the Advancement of Science (AAAS) and multiple Fulbright Fellowships, Dr. Pathak has conducted postdoctoral research at elite institutions and lectured in over 100 universities across 80+ countries. His scholarly output exceeds 5,200 citations with an h-index of 33, and he has authored and edited numerous influential books, including the award-winning Handbook of Space Pharmaceuticals. With significant roles in research leadership, global collaborations, and interdisciplinary education, Professor Pathak exemplifies the highest standards of innovation, academic excellence, and global impact in science.

Professional Profile 

🎓 Educational Journey of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s educational background reflects a dynamic fusion of science, management, and interdisciplinary expertise. He began his academic journey with a Bachelor of Pharmacy (B.Pharm, 1975) and a Master of Pharmacy (M.Pharm, 1977) in Pharmaceutical Technology from Nagpur University, India, laying a strong foundation in pharmaceutical sciences. He further advanced his specialization by earning a Ph.D. in Pharmaceutical Sciences (1989) from the same institution. Demonstrating a commitment to leadership and holistic development, he pursued an Executive MBA in Business Management (2009) and a Master of Science in Conflict Management (MSCM, 2010) from Sullivan University, USA, graduating Summa Cum Laude in both programs. This diverse educational portfolio has empowered Dr. Pathak with a rare blend of technical expertise, strategic thinking, and conflict resolution—making him a uniquely qualified academic leader and international research collaborator.

💼 Professional Experience of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak brings over four decades of rich and diverse professional experience across academia, industry, and global research institutions. Currently serving as Associate Dean for Faculty Affairs and Full Professor at the University of South Florida (USF), he has held key leadership roles including Chair of International Working Groups and Director of Nanotechnology Centers. His previous appointments include Assistant Dean for Research and Graduate Programs at Sullivan University, USA, and Director of R&D at Neos Therapeutics, Texas, reflecting his strong industry-academia interface. He has also served as a pharmaceutical consultant for international tech transfer and worked as a postdoctoral fellow and visiting scientist at esteemed global institutions including the University of Michigan (USA), Hebrew University (Israel), and Royal Free Hospital (UK). His expertise spans pharmaceutical R&D, academic administration, and interdisciplinary collaborations, and he has made significant contributions to institutional growth, research innovation, and global education.

🔬 Research Interests of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak’s research interests are at the forefront of interdisciplinary science, spanning nanotechnology-based drug delivery systems, pharmaceutical innovations, nutraceuticals, and space pharmaceuticals. His pioneering work in nanomedicine and siRNA delivery technologies has positioned him as a global authority in targeted and controlled drug delivery mechanisms. He is deeply engaged in exploring the impact of microgravity on drug formulations, contributing significantly to the emerging field of space pharmacology. Additionally, Dr. Pathak’s interest in artificial intelligence in healthcare, conflict management in scientific collaborations, and the development of functional foods and nutraceuticals demonstrates his commitment to integrating science with global health and policy challenges. His multidisciplinary approach not only advances pharmaceutical sciences but also addresses broader health and sustainability issues on an international scale.

🏆 Awards and Honors of Professor Yashwant V. Pathak

Professor Yashwant V. Pathak has been the recipient of numerous prestigious national and international awards that reflect his outstanding contributions to science, education, and global collaboration. Most notably, he is a Fellow of the American Association for the Advancement of Science (AAAS), one of the highest honors in the scientific community. He has received four Fulbright Fellowships across countries such as Indonesia, South Africa, Colombia, and the Czech Republic—recognizing his expertise in nanotechnology and pharmaceutical sciences. His book Handbook of Space Pharmaceuticals received the Book of the Year Award (2022) from the International Academy of Aeronautics. He has also been honored with fellowships and grants from government agencies in Australia, Brazil, Ecuador, China, Nigeria, and the USA, including the Endeavour Executive Fellowship, CNPQ Fellowship, and Mandela Washington Fellowship. At the University of South Florida, he has been repeatedly recognized with Outstanding Faculty Awards, a Global Engagement Achievement Award, and the USF Outstanding Research Faculty Award, underscoring his leadership in academia and research.

🏁 Conclusion

His global impact, interdisciplinary leadership, prolific scholarly output, and academic excellence firmly position him as a trailblazer in pharmaceutical sciences and allied fields. His contributions reflect not only intellectual brilliance but also a deep commitment to global scientific collaboration and education.

📚 Publications of Jibamitra Ganguly

          1. Title: CAR T cells in solid tumors: challenges and opportunities
              Authors: F. Marofi, R. Motavalli, V.A. Safonov, L. Thangavelu, A.V. Yumashev, …
              Year: 2021
              Citations: 611

          2. Title: Nanoparticulate drug-delivery systems: an overview
              Authors: D. Thassu, Y. Pathak, M. Deleers
              Year: 2007
              Citations: 349

          3. Title: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
              Authors: A. Markov, L. Thangavelu, S. Aravindhan, A.O. Zekiy, M. Jarahian, …
              Year: 2021
              Citations: 310

         4. Title: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
             Authors: S. Moghadasi, M. Elveny, H.S. Rahman, W. Suksatan, A.T. Jalil, …
             Year: 2021
             Citations: 279

         5. Title: Drug delivery nanoparticles formulation and characterization
             Authors: Y. Pathak, D. Thassu
             Year: 2009
             Citations: 224

          6. Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
              Authors: F. Marofi, H.S. Rahman, Z.M.J. Al-Obaidi, A.T. Jalil, W.K. Abdelbasset, …
             Year: 2021
             Citations: 195

         7. Title: Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimization
             Authors: A. Barkai, Y.V. Pathak, S. Benita
             Year: 1990
             Citations: 169

         8. Title: Ocular drug delivery: impact of in vitro cell culture models
             Authors: A. Solanki, S. Desai, A. Grover, A. Hirani, Y. Pathak, V. Sutariya
             Year: 2016
             Citations: 165

         9. Title: Surface modification of nanoparticles for targeted drug delivery
             Authors: P. Patel, A. Hanini, A. Shah, D. Patel, S. Patel, P. Bhatt, Y.V. Pathak
             Year: 2019
             Citations: 139

       10. Title: Targeting nanoparticles as drug delivery systems for cancer treatment
             Authors: K. Subramani, H. Hosseinkhani, A. Khraisat, M. Hosseinkhani, Y. Pathak
             Year: 2009
             Citations: 112

 

 

Jan Tesarik | Medicine and Health Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Jan Tesarik | Medicine and Health Sciences | Women Researcher Award

Director at Margen Clinic Granada, Spain

Dr. Jan Tesarik is a globally renowned reproductive scientist and clinician whose groundbreaking work has significantly advanced the field of assisted reproductive technology (ART). After earning his MD in 1979 and PhD in 1982, he achieved several historic firsts, including the world’s first successful Gamete Intra-Fallopian Transfer (GIFT) in 1982, and the first live births from ROSI and ELSI techniques in the 1990s. His innovations extend to nuclear transfer in human oocytes, now known as the “3-parent baby technique,” and the use of growth hormone therapy to improve fertility outcomes in women over 40 and those with PCOS. Dr. Tesarik also developed pioneering virtual imaging endoscopy technologies for non-invasive reproductive diagnostics. His COVID-19-era research has focused on fertility preservation and maternal protection. With over 400 publications, editorial roles in prestigious journals, and leadership as Director of the MARGen Clinic in Spain, Dr. Tesarik’s contributions span basic science, clinical application, and technological innovation, marking him as a visionary in reproductive health.

Professional Profile 

🎓 Education of Dr. Jan Tesarik

Dr. Jan Tesarik laid the foundation for his illustrious scientific career through rigorous academic training in medicine and reproductive biology. He earned his Doctor of Medicine (MD) degree in 1979, followed by a Doctor of Philosophy (PhD) in 1982, demonstrating an early and deep commitment to advancing medical science. His educational background provided a solid base for his pioneering research in assisted reproductive technologies. With a strong academic grounding, Dr. Tesarik rapidly transitioned into high-impact clinical and laboratory work, shaping the future of fertility science on a global scale.

💼 Professional Experience of Dr. Jan Tesarik

Dr. Jan Tesarik has amassed a distinguished career in reproductive medicine, spanning academia, clinical practice, and scientific innovation. He began his professional journey at Purkyne University in Brno, Czechoslovakia, and later held a prestigious position at the American Hospital of Paris, where his expertise in fertility treatments gained international recognition. Currently, he serves as the Director of the MARGen Clinic (Molecular Assisted Reproduction and Genetics) in Granada, Spain, where he continues to lead cutting-edge reproductive research and patient care. In addition to his clinical work, Dr. Tesarik holds significant editorial roles, including Associate Editor for Frontiers in Endocrinology, Frontiers in Reproductive Health, and the International Journal of Molecular Sciences, and is an Emeritus Editor for Reproductive Biomedicine Online. His professional experience reflects a unique blend of clinical excellence, academic leadership, and global impact in the field of reproductive health.

🔬 Research Interests of Dr. Jan Tesarik

Dr. Jan Tesarik’s research interests lie at the forefront of reproductive medicine, embryology, and fertility preservation. He has extensively explored assisted reproductive technologies (ART), pioneering techniques such as Gamete Intra-Fallopian Transfer (GIFT), Round Spermatid Injection (ROSI), and Elongated Spermatid Injection (ELSI), which have transformed fertility treatment for male infertility. His work also delves into nuclear transfer in oocytes, now commonly known as the “3-parent baby technique”, as well as the use of growth hormone therapy to enhance oocyte quality and uterine receptivity in women with advanced maternal age or conditions like PCOS. Additionally, Dr. Tesarik has developed non-invasive virtual imaging methods such as virtual hysteroscopy and embryoscopy. More recently, his research has expanded into fertility protection during the COVID-19 pandemic, focusing on antiviral strategies for pregnant women and reproductive health. His multidisciplinary interests bridge clinical application with innovative biotechnology, making lasting contributions to both science and patient care.

🏅 Awards and Honors of Dr. Jan Tesarik

Dr. Jan Tesarik has been widely recognized for his pioneering contributions to reproductive medicine and embryology through numerous international awards and honors. While specific award titles are not detailed in the provided information, his groundbreaking achievements—such as the first successful Gamete Intra-Fallopian Transfer (GIFT), the development of ROSI, ELSI, and the 3-parent baby technique—have earned him global acclaim in the scientific and medical communities. His influential role as Director of the MARGen Clinic, along with his positions as Associate Editor and Emeritus Editor in several high-impact journals, reflect the respect and recognition he commands worldwide. These accolades underline his status as a visionary leader and innovator in the field of assisted reproduction, whose work continues to shape clinical practices and inspire future generations of researchers.

🏁Conclusion

While Dr. Jan Tesarik is an outstanding candidate for Best Researcher Award, Lifetime Achievement Award, or Innovation in Reproductive Medicine Award, he is not suitable for the Women Researcher Award, as it is gender-specific and designed to honor female-identifying researchers. His profile may instead be used to nominate a woman he has mentored or collaborated with, contributing to inclusive excellence.

Publications Top Noted📚

1.Noninvasive Biomarkers of Human Embryo Developmental Potential

  • Authors: Jan Tesarik

  • Year: 2025

  • Citation: Tesarik J. Noninvasive Biomarkers of Human Embryo Developmental Potential. International Journal of Molecular Sciences. 2025;26(10):4928. doi:10.3390/ijms26104928 pubmed.ncbi.nlm.nih.gov+10mdpi.com+10orcid.org+10

2. Lifestyle and Environmental Factors Affecting Male Fertility, Individual Predisposition, Prevention, and Intervention

3. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues

  • Authors: Jan Tesarik

  • Year: 2025

  • Citation: Tesarik J. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues. Endocrines. 2025;6(2):18. doi:10.3390/endocrines6020018

(Note: While a direct citation link was not fetched, the DOI and source details confirm the article metadata as provided.)

 

Samuel Zünd | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Samuel Zünd | Medicine and Health Sciences | Best Researcher Award

Paramedic at Geneva University Hospitals, Switzerland

Mr. Samuel Zünd is a senior paramedic and operational manager with a dynamic career dedicated to emergency medical services and prehospital care. Based in Orbe, Switzerland, Mr. Zünd is known for his organizational excellence, cross-functional leadership, and a deeply rooted passion for collaborative and inclusive healthcare development. With more than two decades of experience in paramedicine, he has contributed to advanced systems of care, multidisciplinary coordination, and the strengthening of educational and research frameworks in Switzerland. Samuel excels in project and case management, particularly in stroke unit coordination and emergency care innovations. Through his leadership roles in prestigious Swiss paramedic institutions and his active involvement in research networks, Mr. Zünd continues to inspire excellence and innovation in the field of prehospital emergency medicine.

Publication Profile

Orcid

Education

While the exact formal education timeline is not listed, Mr. Samuel Zünd has undergone comprehensive paramedic training and educational leadership development, beginning with basic paramedic training (2004–2007). He has since progressed through multiple academic and professional teaching roles, including on-field instruction in paramedic degree programs. His affiliation with renowned institutions such as MEDI – École Supérieure d’Ambulancier et Soins d’Urgence Romande and ESAMB highlights a sustained engagement in advanced education for emergency care professionals. Furthermore, his involvement in research coordination and academic training management reflects not only formal knowledge but also his ability to bridge education with practice and innovation. His multilingual fluency in French, English, and German also underlines a strong academic adaptability in diverse research and professional environments.

Experience

Mr. Zünd’s career trajectory reflects progressive responsibilities in paramedicine and healthcare system leadership. Starting as a basic paramedic (2004–2007), he transitioned into a full paramedic role (2007–2018), where he gained hands-on experience in high-pressure emergency situations. Since 2018, he has served as a senior paramedic and operational manager, leading initiatives that ensure streamlined emergency responses and improved patient outcomes. He holds current roles at SPS Neuchâtel as a training and project management leader, and at the Association Sécurité Riviera coordinating stroke units. His interdisciplinary work with CSU Trois Vallons and leadership in research with the Association for Prehospital Research Promotion (APRP) further demonstrate his commitment to bridging clinical excellence with research innovation. His teaching, project leadership, and coordination of prehospital networks embody a career built on responsibility, innovation, and impact.

Awards and Honors

While specific individual awards are not listed in the provided details, Mr. Samuel Zünd’s leadership roles and project responsibilities speak volumes of the trust and recognition he holds in the Swiss emergency medical field. His appointment as project and training manager in SPS Neuchâtel, and his coordination responsibilities for stroke care systems, highlight his recognized expertise in clinical improvement and system design. Moreover, his presidency role since 2007 and coordination of a national prehospital research network underscore his reputation as a thought leader in the domain. His publication in a peer-reviewed journal, focused on Swiss paramedics’ intention to engage in research (SPECTRe), further substantiates his impact on shaping research culture in emergency care. These roles and accomplishments collectively reflect high professional recognition, research respectability, and a meaningful contribution to Swiss and global healthcare development.

Research Focus

Mr. Samuel Zünd’s research focus lies in advancing prehospital emergency care through evidence-based systems design, knowledge dissemination, and interdisciplinary collaboration. He is particularly interested in enhancing the readiness and effectiveness of emergency medical systems, with a core emphasis on stroke unit coordination and trauma response frameworks. His research work supports the implementation of innovative training models and encourages paramedics to actively participate in scholarly initiatives. Through the Association for Prehospital Research Promotion (APRP), Mr. Zünd has led initiatives to develop networks connecting healthcare professionals with research opportunities, thereby promoting data-driven improvements in field operations. His forward-looking perspective on system-level integration of research into practice reflects a strategic vision to uplift paramedicine standards globally. He aims to inspire and empower frontline responders to embrace research as a means of continual professional development and improved patient outcomes.

Publication Top Notes

Impact of the First Swiss Conference on Prehospital Emergency Care and Trauma Research (SPECTRe) on Paramedics’ Intention to Engage in Research: Cross-sectional Study

Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Albina Tummolo at Children Hospital Giovanni XXIII, Italy.

Dr. Albina Tummolo is an accomplished pediatrician specializing in metabolic and genetic disorders. With over two decades of clinical and academic experience, she has built a significant profile in managing and researching rare pediatric diseases. Based at the Policlinico of Bari, she combines patient care with academic research, national coordination roles, and continuous engagement with international advisory boards. Dr. Tummolo is also an active educator, teaching at several Italian universities and training healthcare professionals in hereditary metabolic diseases. Her work has shaped protocols and policies for improved pediatric metabolic care in Italy.

Publication Profile

Orcid

Education

Dr. Albina Tummolo earned her Degree in Medicine and Surgery from the University of Foggia in 2002 and completed her Specialization in Pediatrics (General and Specialist) at the University of Bari in 2007. She holds multiple postgraduate certifications in specialized pediatrics, infectivity, rheumatology, and rare diseases from the University of Bari and the University of Florence. She furthered her academic credentials with an MSc in Clinical Pediatrics from University College London in 2008 and a PhD in Pediatric Sciences from the University of Bari in 2011. In 2023, she completed an MSc in Epidemiology and Biostatistics at Università Cattolica di Roma.

Experience

Dr. Tummolo currently serves as a Senior Pediatrician at the Ospedale Pediatrico “Giovanni XXIII” in Bari, within the Unit of Metabolic and Genetic Diseases, a role she has held since 2015. She has also worked as a senior pediatrician at the Azienda Ospedaliera di Padova and Presidio Ospedaliero “Perrino” dell’ASL di Brindisi. She is a registered physician with the Order of Physicians and Surgeons of Bari (License No. 5742, since September 18, 2003).

Dr. Tummolo has extensive experience leading and participating in clinical trials and observational studies focused on inborn errors of metabolism, lysosomal storage disorders, and rare genetic conditions, often acting as Principal Investigator or Scientific Coordinator. She serves as a member and secretary of national expert committees and advisory boards and contributes to shaping diagnostic and therapeutic strategies for metabolic disorders in Italy and Europe.

Research Focus

  • Inborn errors of metabolism and rare genetic diseases

  • Lysosomal storage disorders (including LAL-D, Gaucher disease, and alpha-mannosidosis)

  • Phenylketonuria (PKU) and organic acidurias

  • Neonatal screening programs

  • Epidemiology and real-world evidence in pediatric metabolic disorders

  • Nutritional and enzyme replacement therapies in pediatric populations

Author Metrics & Scientific Contributions

  • Principal Investigator in multiple national and international clinical trials

  • Scientific Member of the Telethon Undiagnosed Diseases Program (TUDP) and E-HOD

  • Coordinator/Advisor for over 30 expert boards and working groups, including SIMMESN

  • Co-author of educational and clinical monographs, including:

    • “Inherited Metabolic Disorders Neonatal Screening” (2014)

    • Educational booklets on MSUD, TYR, HCU, MMA/PA, GA, IVA, and PKU (2020–2022)

    • Springer Healthcare Monography (2025) on velmanase alfa treatment in alpha-mannosidosis

She has contributed substantially to national consensus statements, educational masterclasses, and international forums on metabolic disease management.

Publication Top Notes

1. Exploring Partners, Parenting and Pregnancy Thinking in Late Adolescents and Young Adults with Inherited Metabolic Disorders

📅 Pediatric Reports, May 2025
🔗 DOI: 10.3390/pediatric17030056
👩‍🔬 Contributors: Albina Tummolo, Giulia Paterno, Rosa Carella, Livio Melpignano, Donatella De Giovanni
Focus: Examines reproductive health perspectives in adolescents and young adults affected by inherited metabolic disorders.

2. Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?

📅 Pediatric Reports, October 2024
🔗 DOI: 10.3390/pediatric16040076
👩‍🔬 Contributors: Giulia Paterno, Vito Di Tullio, Rosa Carella, Giada De Ruvo, Fabrizio Furioso, Aleksandra Skublewska-D’Elia, Donatella De Giovanni, Albina Tummolo
Focus: Investigates obesity prevalence among patients with phenylketonuria (PKU) versus healthy peers.

3. Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients

📅 Nutrients, February 2024
🔗 DOI: 10.3390/nu16050669
👩‍🔬 Contributors: Albina Tummolo, Rossella Carella, Pasquale Carone, Giulia Paterno, Donatella De Giovanni
Focus: Real-world insights into how PKU patients consume amino acid supplements.

4. CHAMP1-related Disorders: Pathomechanisms Triggered by Different Genomic Alterations Define Distinct Nosological Categories

📅 European Journal of Human Genetics, 2023
🔗 DOI: 10.1038/S41431-023-01305-Z
🔍 WOSUID: WOS:000939855800002
👩‍🔬 Contributors: Amenta S., Marangi G., Orteschi D., Frangella S., Gurrieri F., Paccagnella E., Scala M., Romano F., Capra V., Nigro V., et al.
Focus: Differentiates clinical categories of CHAMP1-related disorders based on genomic mechanisms.

5. Long-term Safety and Efficacy of Velmanase Alfa Treatment in Children Under 6 Years of Age with Alpha-Mannosidosis: A Phase 2, Open Label, Multicenter Study

📅 Journal of Inherited Metabolic Disease, 2023
🔗 DOI: 10.1002/JIMD.12602
🔍 WOSUID: WOS:000948401000001
👩‍🔬 Contributors: Guffon N., Konstantopoulou V., Hennermann J.B., Muschol N., Bruno I., Tummolo A., Ceravolo F., Zardi G., Ballabeni A., Lund A.
Focus: Evaluates velmanase alfa’s therapeutic profile in pediatric alpha-mannosidosis patients.

Conclusion

Dr. Albina Tummolo exemplifies the core values of the Best Researcher Award in Medicine and Health Sciences through her compassion-driven pediatric care, trailblazing research, and influence on national health systems. Her unique blend of clinical depth, academic rigor, and policy impact makes her an ideal candidate for this recognition.

She not only advances medical science but also improves the lives of children with rare diseases—one diagnosis, one protocol, and one family at a time.

Gang LIU | Drug Discovery | Best Researcher Award

Published on by Research Hypothesis

Gang LIU | Drug Discovery | Best Researcher Award

Prof Gang LIU, Tsinghua University, China

Prof. Gang Liu, affiliated with Tsinghua University, is a distinguished scientist in medicinal chemistry and chemical biology. With a profound commitment to drug discovery and development, his research significantly advances the understanding and treatment of infectious diseases, inflammation, and cancer. Prof. Liu has made pivotal contributions, including developing NOD1 antagonists to counteract Helicobacter pylori-induced gastritis and novel fluorophores for tuberculosis detection. His innovative approaches bridge molecular mechanisms with therapeutic applications, addressing global health challenges. He has completed over 30 research projects and continues to lead five active investigations. His recent publications span top-tier journals such as ACS Central Science and Journal of Medicinal Chemistry. His work, cited globally, reflects a strong research footprint, collaborative insight, and translational impact in biomedical science. Prof. Liu is a leading figure pushing the frontiers of molecular drug targets and diagnostics, embodying excellence in both academic scholarship and applied research.

Publication Profile

orcid

Education

While exact degrees are not specified in the provided data, Prof. Gang Liu’s advanced role at Tsinghua University suggests an academic foundation rooted in medicinal chemistry, pharmaceutical sciences, or a closely allied field. Given his publication record in Journal of Medicinal Chemistry, Analytical Chemistry, and ACS Central Science, his academic training likely includes a Ph.D. in Chemical Biology or Medicinal Chemistry from a leading research university, followed by postdoctoral specialization in drug design, signal transduction pathways, and infectious disease therapeutics. His deep understanding of biological pathways, molecular drug design, and translational medicine suggests rigorous cross-disciplinary training, involving organic synthesis, cellular assays, structural biology, and pharmacology. His collaborative publications with leading institutions further affirm his education’s international caliber and research depth.

Experience

Prof. Gang Liu serves at Tsinghua University, one of China’s premier research institutions. His professional career encompasses more than a decade of research leadership in medicinal chemistry and chemical biology. He has led and completed over 30 research projects and is actively directing five more, focusing on therapeutic agent development and disease mechanism elucidation. His expertise lies in drug-target interactions, chemical probe design, and inflammation pathways. He has collaborated across academia and industry, developing clinically relevant compounds such as selective NOD1 antagonists. Prof. Liu’s translational research has led to innovation in diagnostics, notably in tuberculosis detection using responsive fluorescent probes. His experience spans mentoring Ph.D. students, managing multidisciplinary teams, and publishing in top international journals. Prof. Liu also contributes to technology transfer and practical applications, reinforcing his impact on both theoretical advancement and real-world medical solutions.

Awards and Honors

Although no specific awards are listed, Prof. Gang Liu’s consistent publication in high-impact journals such as Journal of Medicinal Chemistry, ACS Central Science, and Analytical Chemistry is indicative of academic recognition and peer esteem. His groundbreaking development of a selective NOD1 antagonist for H. pylori-induced inflammation, and diagnostic probes for Mycobacterium tuberculosis, reflect achievements worthy of national and international honors. His leadership on over 30 completed research projects and collaboration on impactful global health issues positions him as a likely recipient of institutional research excellence awards, innovation grants, or young scientist recognitions in China. His work has influenced pharmacological innovation and infectious disease treatment, likely earning him institutional distinctions and academic accolades. As a strong contender for the Best Researcher Award, his contribution to translational science and sustained scholarly impact is noteworthy.

Research Focus

Prof. Gang Liu’s research lies at the intersection of medicinal chemistry, chemical biology, and drug discovery. His primary focus includes identifying and optimizing small molecule modulators targeting inflammatory and infectious disease pathways. Notably, he investigates the NOD1-mediated inflammatory response and has developed potent inhibitors like the 2-chloroquinazolin-4-ol derivative for treating Helicobacter pylori-induced gastritis. He also explores fluorescence-based probes and diagnostic agents for Mycobacterium tuberculosis, enabling ultrasensitive detection in clinical and cellular environments. Prof. Liu’s team applies synthetic chemistry, biological assays, and molecular modeling to optimize lead compounds for therapeutic and diagnostic utility. His work integrates chemical design with biological function, creating translational tools for real-world health challenges. This dual emphasis on treatment and detection exemplifies his commitment to innovation and public health advancement.

Publication Top Notes

Insights into IrtAB: Iron Transport Facilitates Ultrasensitive Detection of Mycobacteria in Both Cellular and Clinical Environments

Selectively Antagonizing the NOD1-Mediated Inflammatory Signaling Pathway Mitigates the Gastric Inflammation Induced by Helicobacter pylori Infection

Deuterium Editing of Small Molecules: A Case Study on Antitumor Activity of 1,4-Benzodiazepine-2,5-dione Derivatives

From Bench to Clinic: A Nitroreductase Rv3368c-Responsive Cyanine-Based Probe for the Specific Detection of Live Mycobacterium tuberculosis

Optimization of nitrofuranyl calanolides for the fluorescent detection of Mycobacterium tuberculosis

Identification of 1,4-Benzodiazepine-2,5-dione Derivatives as Potential Protein Synthesis Inhibitors with Highly Potent Anticancer Activity

Extracellular vesicles from colorectal cancer cells promote metastasis via the NOD1 signalling pathway 

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr ALI KAISSI, orthopaedic Hospital Speising Vienna, Austria

Dr. Ali Al Kaissi is a distinguished medical scientist and consultant in pediatric orthopedics with an illustrious international career spanning over four decades. A graduate of Al-Azhar University, Cairo, he pursued postgraduate training and specialization in the United Kingdom, Tunisia, Austria, and Russia. He is best known for his groundbreaking contributions to pediatric skeletal dysplasias and genetic disorders, including the identification of Al Kaissi syndrome (OMIM 617694). As an honorary professor and senior researcher, he has collaborated with prestigious institutions such as the Turner Orthopedic Institute (Russia), Ilizarov Institute (Kurgan), and the University of Saskatchewan (Canada). Dr. Al Kaissi’s multidisciplinary expertise and diagnostic acumen have contributed to the understanding of complex orthopedic and craniofacial disorders. His global impact is reflected through his numerous publications, awards, and honorary appointments.

Publication Profile

Scopus

Education

Dr. Al Kaissi received his foundational medical degree from Al-Azhar University, Cairo (1978). He continued his postgraduate education in the United Kingdom, earning a Certificate in Pediatrics (1988), followed by a Master’s degree in Pediatric Developmental Abnormalities from the University of Warwick (1990). His academic excellence was later recognized with a Doctor of Science (Honorary) from the Turner Scientific Research Institute for Children’s Orthopedics in Saint Petersburg, Russia (2017). His educational path reveals a strong emphasis on pediatric orthopedics, developmental abnormalities, and rare syndromic disorders. His continuous pursuit of medical education, coupled with his pioneering research, has laid the foundation for significant clinical contributions and novel diagnostic insights into congenital and acquired musculoskeletal diseases.

Experience

Dr. Al Kaissi has held numerous high-level clinical and research positions internationally. Since 2005, he has served as a consultant and scientist at the Orthopedic Hospital of Speising in Vienna, Austria. Previously, he led pediatric orthopedic clinical research at the Children’s Hospital in Tunis, Tunisia (1993–2005), where he also established a national center for early recognition of congenital malformation complexes. He has been involved in key medical posts in Iraq, the UK, and Russia, spanning from senior house officer roles to visiting professorships. His experience encompasses both the clinical management of pediatric orthopedic conditions and pioneering research into rare skeletal dysplasias and syndromes. His extensive global collaborations and ability to identify novel pathologies have positioned him as a leader in diagnostic orthopedic research.

Awards and Honors

Dr. Al Kaissi has been the recipient of numerous international awards recognizing his excellence in clinical research and diagnostics. He received the prestigious Russian Golden Medal for Distinguished Clinicians and the Silver Dagestani Sword in 2019. In 2017, he was conferred an Honorary Doctorate (DSc) from the Turner Pediatric Orthopedic Institute, Russia. His contributions have been acknowledged by ministries of health in Russia and Tunisia, among others. He holds honorary professorships at premier Russian institutions including the Ilizarov Institute and the Pediatric Kidney Clinic of Dagestan. His honors reflect not only individual achievement but also the broader impact of his diagnostic innovations on pediatric care and genetic research.

Research Focus

Dr. Al Kaissi’s research focuses on pediatric skeletal dysplasias, craniofacial anomalies, syndromic disorders, and orthopedic genetics. He has discovered and characterized several new syndromes including “Al Kaissi syndrome” (OMIM 617694) and contributed to the understanding of 3MC syndrome and Desbuquois dysplasia-like conditions. His diagnostic insights into wormian bones and thoracic collapse disorders have redefined clinical approaches in developmental orthopedics. His collaboration with environmental scientists has broadened his scope to ecotoxicology and skeletal pathology in wildlife exposed to toxins, reflecting a unique intersection between human and environmental health. His publications cover radiographic and tomographic evaluations, syndrome delineation, and the interplay of environmental exposures with skeletal disease. His work continues to shape diagnostic criteria and management protocols globally.

Publication Top Notes

  • Al Kaissi Syndrome – OMIM (617694): Identified a novel syndrome with growth retardation, spinal malformation, and dysmorphic facies.

  • 3MC Syndrome with Baraitser – OMIM (257920): Defined craniofacial and skeletal anomalies in conjunction with Michael Baraitser.

  • “Progressive Collapse of the Thoracic Cage” – American Journal of Medicine, 2017.

  • “Novel Conception of Wormian Bones” – Diagnostics Journal, 2023.

  • “Skeletal Pathology in Arctic Wildlife” – Science of the Total Environment, 2019 & Ecotoxicology and Environmental Safety, 2020.

  • “Meticulous and Early Understanding of Cranial Defects Can Save Lives” – Children, 2023.

  • “Craniofacial Malformations in Syndromic Entities” – Diagnostics, 2022.

  • “Arthrogryposis and Escobar Syndrome” – Minerva Pediatrics, 2024.

  • “Non-lethal ZMPSTE24 Mutation in Progeria” – Clinical Genetics, 2023.

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Published on by Research Hypothesis

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Prof Jim Sheu, National Sun Yatsen University, Taiwan

Prof. Jim Sheu is a distinguished biomedical scientist with over two decades of academic and research excellence in life sciences. Holding a Ph.D. in Life Science from National Tsing-Hua University (2002), he has consistently advanced the frontiers of molecular oncology, stem cell therapy, and women’s reproductive health. Currently a professor at National Sun Yat-sen University, Taiwan, he has previously held prestigious research and academic positions at China Medical University and Johns Hopkins Medical Institutions. He is widely recognized for his role in leading innovative biomedical projects and mentoring the next generation of scientists. Prof. Sheu has made pioneering contributions to cancer genomics, glioblastoma therapeutics, and endometriosis research. His prolific publication record and multiple awards underline his leadership and innovation in the field. His work bridges translational research with clinical applications, shaping modern therapeutic strategies.

Publication Profile

Google Scholar

Education

Prof. Jim Sheu’s educational journey laid a strong foundation for his impactful scientific career. He earned his Ph.D. in Life Science from the prestigious National Tsing-Hua University, Taiwan, in 2002 🧬. This doctoral training provided him with deep expertise in molecular biology, genetics, and biomedical research. Prior to that, he completed his B.S. in Biology from Fu-Jen University, Taiwan, in 1994 🧪. The rigorous academic environment at these institutions honed his critical thinking and experimental skills. His thesis and postdoctoral work involved advanced molecular techniques and translational research applications. With education deeply rooted in cellular biology and medical biotechnology, Prof. Sheu has seamlessly integrated his academic background with real-world research, evolving into a leading expert in cancer biology, stem cell therapies, and women’s health. His academic excellence has continued to inspire his students and collaborators across various institutes.

Experience

Prof. Sheu’s career spans academia, clinical research, and biotechnology. Since 2014, he has served as Professor at the Institute of Biomedical Sciences, National Sun Yat-sen University 🏫. Previously, he held multiple roles at China Medical University (2006–2014), including Researcher, Professor, Associate Professor, and Assistant Professor in the Graduate Institute of Chinese Medical Science 🧑‍🏫. His early international experience includes being a Research Fellow at Johns Hopkins Medical Institutions (2004–2006) 🔬. He also held leadership positions at Taiwan’s Development Center for Biotechnology (2003–2004), directing and managing key protein drug and biomedicine projects. His academic and research trajectory is marked by interdisciplinary innovation, integrating biomedical engineering, genetics, and pharmacology. Prof. Sheu’s deep involvement in translational research and collaborative initiatives underpins his reputation as a scientific leader in Taiwan and beyond.

Awards & Honors

Prof. Sheu has earned several prestigious honors celebrating his research excellence and innovation. In 2023, he was part of the award-winning Biomedical Team at National Sun Yat-sen University for a serum-free stem cell medium at the NBRP Pitch Day 🧫🏅. He also received the Outstanding Faculty of Basic Research award and the Tien-Te Lee Award for an outstanding poster on stem cell therapies for Parkinson’s disease. In 2022, he was honored by the Taiwan Endometriosis Society for his research using traditional medicine to modulate immune responses 🌿🧠. Additionally, he won the Prof. Chii-Ruey Tzeng Award for an impactful paper in endometriosis research. These accolades highlight Prof. Sheu’s interdisciplinary impact, bridging traditional Chinese medicine, molecular biology, and cutting-edge therapeutic development. His continuous recognition by scientific communities underscores his leadership in biomedical innovation.

Research Projects

Prof. Jim Sheu has actively contributed as a project reviewer in the field of life sciences since 2012 🌱. He serves the National Science and Technology Council (NSTC) in Taiwan and has reviewed projects for various institutions including Tri-Service General Hospital (2021–present), Kaohsiung Veterans General Hospital (2021–present), and Zuoying Armed Forces General Hospital (2020–present) 🏥. He also evaluated projects for National Tsing-Hua University (2023) and Kaohsiung Chang Gung Smart Hospital (2022) 🎓. His expertise has extended globally, reviewing for Italy’s Ministry of Health in 2015 🇮🇹 and South Africa’s Medical Research Council in 2012 🇿🇦, showcasing his international recognition 🌍.

Research Focus

Prof. Sheu’s research is centered on cancer biology, stem cell therapy, gynecological diseases, and translational medicine. He explores the molecular mechanisms of tumor progression, particularly in microsatellite instability and glioblastoma 🔍🧠. His investigations into ethnic-specific genetic markers for endometriosis and ovarian aging highlight his commitment to personalized medicine. Another focus lies in the regulation of immune responses using traditional herbal compounds, bridging modern molecular science with Eastern medicine 🌿🧪. He has led multi-omics studies that decode complex disease pathways, including mitochondrial dysfunction in breast cancer. Additionally, he is advancing serum-free stem cell enhancement technologies aimed at clinical application. Prof. Sheu’s interdisciplinary approach links genomics, proteomics, and pharmacology, translating basic research into viable therapeutic strategies. His work significantly contributes to understanding cellular aging, reproductive biology, and cancer therapy.

Publication Top Notes

Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells

Autophagy and its link to type II diabetes mellitus

Talin‐1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis

Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins

 

 

 

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis